Quick Answer
PDS Biotechnology Corp reported Research And Development Expense of $19.03 million for the year ending 2025.
- PDS Biotechnology Corp showed a decrease of -15.7% in Research And Development Expense from 2024 to 2025.
- This data is from PDS Biotechnology Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $2.42 million | Q1 2015: $2.87 million | Q2 2015: $3.20 million | Q3 2015: $6.51 million | Q1 2016: $5.35 million | Q2 2016: $5.98 million | Q3 2016: $6.72 million | Q1 2017: $7.59 million | Q2 2017: $8.98 million | Q3 2017: $6.91 million | Q1 2018: $201.1 thousand | Q2 2018: $168.6 thousand | Q3 2018: $194.1 thousand | Q1 2019: $1.03 million | Q2 2019: $1.89 million | Q3 2019: $1.83 million | Q1 2020: $1.97 million | Q2 2020: $1.41 million | Q3 2020: $2.06 million | Q1 2021: $1.41 million | Q2 2021: $2.76 million | Q3 2021: $3.69 million | Q1 2022: $5.16 million | Q2 2022: $3.76 million | Q3 2022: $4.35 million | Q1 2023: $5.84 million | Q2 2023: $8.00 million | Q3 2023: $6.45 million | Q1 2024: $6.70 million | Q2 2024: $4.53 million | Q3 2024: $6.80 million | Q1 2025: $5.83 million | Q2 2025: $4.21 million | Q3 2025: $4.58 million.
- Over the full 13 years of available data (2013 to 2025), PDS Biotechnology Corp's Research And Development Expense has grown by 324.3%.
- Historical annual values: Fiscal year 2025: $19.03 million | Fiscal year 2024: $22.57 million | Fiscal year 2023: $27.76 million | Fiscal year 2022: $29.43 million | Fiscal year 2021: $11.25 million | Fiscal year 2020: $7.92 million | Fiscal year 2019: $6.10 million | Fiscal year 2018: $830.7 thousand | Fiscal year 2017: $34.31 million | Fiscal year 2016: $24.83 million | Fiscal year 2015: $17.84 million | Fiscal year 2014: $8.47 million | Fiscal year 2013: $4.48 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: